EUVIMEDEUVIMED entdecken
Crossref

Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes

Hyunhwa La, Jinwoong Kim, Dae-Hoon Kim, Seong-Heon Kim, Pargat Singh iD, Gibeom Nam, Kyeongwon Moon, Ikyon Kim iD, In Su Kim iD

Journal of Medicinal Chemistry · 27.02.2025 · 68 (4) · 4619-4634

DOI: 10.1021/acs.jmedchem.4c02655 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, online erschienen am 24.01.2025. Verfasst von Hyunhwa La und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Receptors, G-Protein-Coupled, Hypoglycemic Agents, Cyclohexenes. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Receptors, G-Protein-CoupledHypoglycemic AgentsCyclohexenesAnimalsMiceHumansRatsFemaleStructure-Activity RelationshipMaleDrug DiscoveryObesityRats, Sprague-DawleyMice, Inbred C57BLGlucose Tolerance Test

Substanzen

Receptors, G-Protein-CoupledHypoglycemic AgentsGPR119 protein, humanCyclohexenescyclohexene

Autor:innen und Institutionen

  • School of Pharmacy, Sungkyunkwan University, Suwon 16419, Republic of Korea.
  • Medicinal Chemistry Research Team, New Drug Discovery Lab., Hyundai Pharmaceutical Co. Ltd., Suwon 16229, Republic of Korea.
  • College of Pharmacy and Yonsei Institute of Pharmaceutical Sciences, Yonsei University, Incheon 21983, Republic of Korea.
  • Nonclinical Research Team, New Drug Discovery Lab., Hyundai Pharmaceutical Co. Ltd., Yongin 17089, Republic of Korea.

ORCID-Profile: Pargat Singh, Ikyon Kim, In Su Kim

Förderung

  • Korea Health Industry Development Institute
  • National Research Foundation of Korea

Zitieren

APA

La, H., Kim, J., Kim, D. H., Kim, S. H., Singh, P., Nam, G., Moon, K., Kim, I., & Kim, I. S. (2025). Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry, 68(4), 4619-4634. https://doi.org/10.1021/acs.jmedchem.4c02655

Vancouver

La H, Kim J, Kim DH, Kim SH, Singh P, Nam G, et al. Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes. Journal of Medicinal Chemistry. 2025;68(4):4619-4634. doi:10.1021/acs.jmedchem.4c02655

BibTeX
@article{La2025,
  author = {La, Hyunhwa and Kim, Jinwoong and Kim, Dae-Hoon and Kim, Seong-Heon and Singh, Pargat and Nam, Gibeom and Moon, Kyeongwon and Kim, Ikyon and Kim, In Su},
  title = {Discovery of 1,4-Disubstituted Cyclohexene Analogues as Selective GPR119 Agonists for the Treatment of Type 2 Diabetes},
  journal = {Journal of Medicinal Chemistry},
  year = {2025},
  volume = {68},
  number = {4},
  pages = {4619--4634},
  doi = {10.1021/acs.jmedchem.4c02655}
}
Kostenlos starten →